LifeMD, Inc.
LFMD
$6.09
$0.030.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 39.27% | 42.16% | 38.63% | 32.85% | 28.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.27% | 42.16% | 38.63% | 32.85% | 28.15% |
| Cost of Revenue | 27.34% | 13.52% | 12.62% | 9.36% | 1.25% |
| Gross Profit | 40.96% | 46.42% | 42.73% | 36.78% | 33.16% |
| SG&A Expenses | 36.93% | 38.24% | 32.54% | 18.82% | 3.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 45.65% | 47.04% | 32.52% | 5.58% | -3.71% |
| Total Operating Expenses | 36.86% | 37.04% | 31.64% | 18.89% | 5.24% |
| Operating Income | -11.43% | -0.83% | 10.30% | 39.50% | 63.49% |
| Income Before Tax | -5.26% | 16.67% | 22.28% | 40.80% | 61.01% |
| Income Tax Expenses | -6.07% | 83.12% | 18.66% | 18.66% | 18.66% |
| Earnings from Continuing Operations | -4.99% | 15.30% | 21.76% | 40.19% | 60.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 94.44% | 87.65% | 18.60% | -118.81% | -435.76% |
| Net Income | 8.32% | 21.85% | 21.56% | 35.56% | 54.77% |
| EBIT | -11.43% | -0.83% | 10.30% | 39.50% | 63.49% |
| EBITDA | -10.22% | 0.15% | 10.99% | 41.15% | 65.51% |
| EPS Basic | 23.47% | 35.03% | 33.09% | 41.00% | 55.11% |
| Normalized Basic EPS | 28.66% | 31.52% | 24.96% | 34.28% | 52.60% |
| EPS Diluted | 23.13% | 34.25% | 32.36% | 40.87% | 55.09% |
| Normalized Diluted EPS | 28.66% | 31.52% | 24.96% | 34.28% | 52.60% |
| Average Basic Shares Outstanding | 21.64% | 22.42% | 19.88% | 14.56% | 9.23% |
| Average Diluted Shares Outstanding | 21.64% | 22.42% | 19.88% | 14.56% | 9.23% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.09% | -0.28% | -0.27% | -0.55% | -1.21% |